/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mary W. Redman

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa(ZA)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

437

Papers

7.3K

Citations

44

h-index

110

i10-index

Mary W. Redman is an academic researcher from Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers. The author has an h-index of 44, co-authored 372 publications.

ORCID: 0000-0003-2294-9674

Research Topics

Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies Colorectal Cancer Screening and Detection

Papers by this author

works

SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

2019 · Journal of Thoracic Oncology · 86 citations

https://doi.org/10.1016/j.jtho.2019.05.029

Corey J. Langer Mary W. Redman James L. Wade Charu Aggarwal

Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer

2017 · British Journal of Cancer · 51 citations

https://doi.org/10.1038/bjc.2017.266

Zixu Yuan Kelsey K. Baker Mary W. Redman Lei Wang

International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy

2023 · Journal of Thoracic Oncology · 37 citations

https://doi.org/10.1016/j.jtho.2023.07.017

Sanja Đačić William D. Travis Mary W. Redman Anjali Saqi

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929

2024 · Journal of Thoracic Oncology · 25 citations

https://doi.org/10.1016/j.jtho.2024.10.021

Nagla Abdel Karim Jieling Miao Karen L. Reckamp Carl M. Gay

The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases

2017 · Clinical Epigenetics · 23 citations

https://doi.org/10.1186/s13148-017-0347-1

Stacey A. Cohen Ming Yu Kelsey K. Baker Mary W. Redman

S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma

2024 · JTO Clinical and Research Reports · 4 citations

https://doi.org/10.1016/j.jtocrr.2024.100738

Anne S. Tsao Ming-Hui Hsieh Marianna Koczywas Janet Tu

Research topics

topics

Lung Cancer Treatments and Mutations

Cancer Genomics and Diagnostics

Cancer Immunotherapy and Biomarkers

Lung Cancer Research Studies

Colorectal Cancer Screening and Detection

Chat about Author

Papers

Chat

Click to start Chat